Possemato (14) reported that the PHGDH gene is in a genomic region of recurrent copy number gain in breast cancer, and the PHGDH protein levels are elevated in 70% of estrogen receptor-negative breast cancers. This evidence concerns the gene PHGDH and breast cancer.